HDA’s John M. Gray Highlights State of the Distribution Industry in Chain Drug Review

June 5, 2017

Ahead of the HDA Business and Leadership Conference, President and CEO John M. Gray was interviewed by Chain Drug Review as part of the publication’s “Annual Report of Drug Wholesalers.”

Published in the June 5 issue, Mr. Gray notes that HDA’s primary pharmaceutical distributor members are ensuring the safety and efficiency of the pharmaceutical supply chain like never before, while discussing such policy issues as DSCSA implementation, prescription drug importation proposals, prescription drug abuse and tax issues.